Cargando…

Aluminum Nanoparticles Acting as a Pulmonary Vaccine Adjuvant-Delivery System (VADS) Able to Safely Elicit Robust Systemic and Mucosal Immunity

ABSTRACT: Vulnerability of respiratory mucosa to invasions of airborne pathogens, such as SARS-CoV, MERS-CoV and avian viruses which sometimes cause a life-threatening epidemic and even pandemic, underscores significance of developing a pulmonary vaccine adjuvant-delivery system (VADS). Herein, 30-n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ning, Wei, Chunliu, Zhang, Zina, Liu, Ting, Wang, Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210793/ https://www.ncbi.nlm.nih.gov/pubmed/32395098 http://dx.doi.org/10.1007/s10904-020-01572-z

Ejemplares similares

Robust Audio Content Classification Using Hybrid-Based SMD and Entropy-Based VAD
por: Wang, Kun-Ching
Publicado: (2020)

(333) Transitioning Vad Care: Outcomes of Virtual Vad Follow Up Visits
por: Meehan, K., et al.
Publicado: (2023)

Work for the V.A.D.s.
Publicado: (1919)

The Victimisation of V.A.D.s.
por: Green, J. E.
Publicado: (1919)

Editorial: Hemostasis in ECMO and VAD
por: Teruya, Jun, et al.
Publicado: (2019)

The Victimisation of V.A.D.s.
Publicado: (1919)

Implantable ventricular assistance systems (VAD) as a bridge to transplant or as ‘destination therapy’
por: Nesta, Marialisa, et al.
Publicado: (2021)

The Control of V.A.D. Hospitals
Publicado: (1918)

To VAD or Not to VAD: A Case of Durable Left Ventricular Assist Device Implantation in a COVID-19 Patient
por: Ignaszewski, M., et al.
Publicado: (2021)

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates
por: Pierantoni, Angiolo, et al.
Publicado: (2015)

Intravaginal immunization using a novel antigen delivery device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses
por: McKay, PF, et al.
Publicado: (2012)

Evaluation of Mucosal and Systemic Immune Responses Elicited by GPI-0100- Adjuvanted Influenza Vaccine Delivered by Different Immunization Strategies
por: Liu, Heng, et al.
Publicado: (2013)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

VAD chemotherapy as remission induction for multiple myeloma.
por: Anderson, H., et al.
Publicado: (1995)

Some Difficulties with V.A.D. Workers
Publicado: (1916)

Some Difficulties with V.A.D. Workers
Publicado: (1916)

V.A.D.'s Casualty Clearing Stations
Publicado: (1919)

Joint Women's V.A.D. Department
por: Oliver, B. C.
Publicado: (1919)

VAD Patients’ Perception of Potential Telemedicine Support
por: Berg, Thomas, et al.
Publicado: (2022)

Editorial: Hemostasis in ECMO and VAD, volume II
por: Teruya, Jun, et al.
Publicado: (2023)

The VAD Scheme versus Thalidomide plus VAD for Reduction of Vascular Endothelial Growth Factor in Multiple Myeloma: A Meta-Analysis
por: He, Gan-Lin, et al.
Publicado: (2018)

Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
por: Deimel, Lachlan P., et al.
Publicado: (2022)

Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity
por: Kim, Eun-Do, et al.
Publicado: (2015)

Improved Aluminum Adjuvants Eliciting Stronger Immune Response When Mixed with Hepatitis B Virus Surface Antigens
por: Wang, Zhibiao, et al.
Publicado: (2022)

Research Progress of Aluminum Phosphate Adjuvants and Their Action Mechanisms
por: Zhang, Ting, et al.
Publicado: (2023)

Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance
por: Xie, Emily, et al.
Publicado: (2015)

Polymyxins as Novel and Safe Mucosal Adjuvants to Induce Humoral Immune Responses in Mice
por: Yoshino, Naoto, et al.
Publicado: (2013)

Is there a role for ‘modified VAD’ in the treatment of multiple myeloma?
por: Agazzi, A, et al.
Publicado: (2009)

The Payment of Medical Officers in V.A.D. Hospitals
Publicado: (1917)

More V.A.D.s of All Ranks Wanted
por: Stanley, Arthur, et al.
Publicado: (1916)

Thrombolytics in VAD management — A single-center experience
por: Nair, N., et al.
Publicado: (2016)

P19-46. Co-delivery of mucosal chemokine plasmids in a systemically delivered DNA vaccine elicits systemic and mucosal immune responses in mice and macaques
por: Kraynyak, KA, et al.
Publicado: (2009)

The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants
por: Kim, Sae-Hae, et al.
Publicado: (2017)

Correction: Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance
por: Xie, Emily, et al.
Publicado: (2016)

Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022)

The effect of captopril on the performance of the control strategies of BJUT-II VAD
por: Gu, Kaiyun, et al.
Publicado: (2016)

Aluminum Adjuvants—‘Back to the Future’
por: Laera, Donatello, et al.
Publicado: (2023)

Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses
por: McKay, Paul F., et al.
Publicado: (2017)

IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates
por: Logerot, Sandrine, et al.
Publicado: (2021)

Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization
por: Wang, Ning, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_et7cqpunju1mtbrpfhl5t62gqa